Trademark: 98081534
Word
RINREYA
Status
Pending
Status Code
686
Status Date
Tuesday, May 7, 2024
Serial Number
98081534
Mark Type
4
Filing Date
Wednesday, July 12, 2023
Published for Opposition
Tuesday, May 7, 2024
Trademark Owner History
Takeda Pharmaceuticals International AG - Owner At Publication
Classifications
5 (Based on 44(e)) (Based on Intent to Use) Pharmaceutical preparations for the treatment of seizures associated with Dravet Syndrome and Lennox-Gastaut Syndrome
Trademark Events
Jul 15, 2023
New Application Entered
Jul 18, 2023
New Application Office Supplied Data Entered
Nov 9, 2023
Teas Voluntary Amendment Received
Mar 20, 2024
Assigned To Examiner
Mar 22, 2024
Preliminary/Voluntary Amendment - Entered
Mar 27, 2024
Examiners Amendment -Written
Mar 27, 2024
Examiners Amendment E-Mailed
Mar 27, 2024
Notification Of Examiners Amendment E-Mailed
Mar 27, 2024
Examiner's Amendment Entered
Mar 28, 2024
Examiners Amendment -Written
Mar 28, 2024
Examiners Amendment E-Mailed
Mar 28, 2024
Notification Of Examiners Amendment E-Mailed
Mar 28, 2024
Examiner's Amendment Entered
Mar 29, 2024
Approved For Pub - Principal Register
Apr 17, 2024
Notification Of Notice Of Publication E-Mailed
May 7, 2024
Published For Opposition
May 7, 2024
Official Gazette Publication Confirmation E-Mailed
May 10, 2024
Teas Delete 1(B) Basis Received
KLEER
TABAYOK
Trademark Alertz updated from USPTO on 2030-01-24

Trademark Alertz ™ - GRJR PTY LTD 2024 - Privacy Policy - Terms of Use

The information provided on Trademark Alertz is not legal or professional advice. Information may have been obtained from third parties and may contain errors. You must make your own enquiries and seek independent advice from relevant industry professionals before acting or relying on any information from Trademark Alertz. All trade mark information has been obtained from and made publicly available by The United States Patent and Trademark Office (USPTO). Copyright of the trademark data resides with USPTO. www.uspto.gov